Drug Use-Results Survey of KYPROLIS
Not Applicable
Completed
- Conditions
- Multiple myeloma
- Registration Number
- JPRN-jRCT1080224009
- Lead Sponsor
- ONO PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
All patients with relapsed or refractory multiple myeloma to whom KYPROLIS was administered
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety<br>efficacy<br>Safety items : Occurrence of adverse drug reactions/infections, factors considered to influence the safety<br>Efficacy items : Comprehensive improvement, factors considered to influence the efficacy
- Secondary Outcome Measures
Name Time Method other<br>-